NIH #5U01CA263986-04
Evaluation of Patient Factors and Sample Pre-Analytics on Predictive Multiplex Immunohistochemical Assays in Immuno-Oncology Patients
- Amount
- $261K
- Period
- 2023-08-01 → 2027-11-30
- PIs
- 1
- Est. capacity / PI
- ~1 students
Cancer Genomics and Diagnostics · Cancer Research
15 total · 3 active
NIH #5U01CA263986-04
NIH #5U01CA263986-03
NIH #7U01CA263986-02
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Biomarker Research · 2025-11-27
bioRxiv (Cold Spring Harbor Laboratory) · 2025-11-24
C1orf50 Accelerates Epithelial-Mesenchymal Transition and the Cell Cycle of Hepatocellular Carcinoma
Cancer Genomics & Proteomics · 2025-10-28 · 1 citations
Nature Communications · 2025-09-03
C1orf50 Drives Malignant Melanoma Progression Through the Regulation of Stemness
Cancer Genomics & Proteomics · 2025-06-26 · 1 citations
Self-assembling protein nanoparticles for cytosolic delivery of nucleic acids and proteins
Nature Biotechnology · 2025-05-15 · 42 citations
Laboratory Investigation · 2025-03-01
Cancers · 2025-02-14 · 3 citations
Preprints.org · 2024-12-19
The role of C1orf50 in breast cancer progression and prognosis
Breast Cancer · 2024-11-27 · 2 citations
The 2024 Report on the Human Proteome from the HUPO Human Proteome Project
Journal of Proteome Research · 2024-11-08 · 26 citations
npj Precision Oncology · 2024-10-03 · 4 citations
The Role of C1orf50 in Breast Cancer Progression and PrognosisPreprint
Research Square · 2024-08-09
iScience · 2024-07-20 · 9 citations